Kagiso Modise is a Pharmacovigilance Officer at the Botswana Medicines Regulatory Authority (BoMRA), with five years of experience supporting the Botswana national pharmacovigilancesystem strengthening. She contributes to key regulatory safety functions including adverse event assessment, signal detection and validation, Periodic Safety Update Report (PSUR) review, Risk Management Plan (RMP) evaluation, and implementation of Materiovigilance activities. She is also experienced in Good Pharmacovigilance Practice (GVP) inspections and broader regulatory compliance activities.

She contributes to initiatives promoting the safe use of medical products among healthcare professionals, patients, and public health programmes. These efforts focus on improving spontaneous reporting and strengthening the use of digital tools to enhance adverse event reporting and data quality. Her interests focus on strengthening reporting systems, improving signal management processes, and advancing practical risk minimisation strategies to enhance
medicine safety in resource-limited settings.

Kagiso represents BoMRA in regional pharmacovigilance activities and contributes to the AU-3S Signal Validation Therapeutics Hub and the ISoP Special Interest Group on Risk Minimisation Methods, supporting the development of feasible and sustainable pharmacovigilance practices.